Bio-Rad Laboratories (NYSE:BIO) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the ...
Supreme Court of Georgia could soon clarify whether plaintiffs without current injuries can recover medical monitoring for potential future illness—and under which legal standards. Justices to hear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results